0000899243-21-014405.txt : 20210401
0000899243-21-014405.hdr.sgml : 20210401
20210401184824
ACCESSION NUMBER: 0000899243-21-014405
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210330
FILED AS OF DATE: 20210401
DATE AS OF CHANGE: 20210401
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Schor Chen
CENTRAL INDEX KEY: 0001340875
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38359
FILM NUMBER: 21799903
MAIL ADDRESS:
STREET 1: PREDIX PHARMACEUTICALS HOLDINGS, INC.
STREET 2: 4 MAGUIRE ROAD
CITY: LEXINGTON
STATE: MA
ZIP: 02421
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Adicet Bio, Inc.
CENTRAL INDEX KEY: 0001720580
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 813305277
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 500 BOYLSTON STREET
STREET 2: 12TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02116
BUSINESS PHONE: 617-482-2333
MAIL ADDRESS:
STREET 1: 500 BOYLSTON STREET
STREET 2: 12TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02116
FORMER COMPANY:
FORMER CONFORMED NAME: resTORbio, Inc.
DATE OF NAME CHANGE: 20171024
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-03-30
0
0001720580
Adicet Bio, Inc.
ACET
0001340875
Schor Chen
C/O ADICET BIO, INC.
500 BOYLSTON STREET, 13TH FLOOR
BOSTON
MA
02116
1
1
0
0
President and CEO
Common Stock
2021-03-30
4
S
0
3582
12.30
D
149128
I
See footnote
Common Stock
2021-03-30
4
S
0
2984
12.30
D
124245
I
See footnote
Common Stock
2021-03-30
4
S
0
5400
13.22
D
143728
I
See footnote
Common Stock
2021-03-30
4
S
0
4500
13.22
D
119745
I
See footnote
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $11.88 to $12.87, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $12.93 to $13.62, inclusive.
Represents 143,728 shares held directly by an irrevocable family trust having an independent trustee.
Represents 119,745 shares held directly by an irrevocable family trust having an independent trustee.
/s/ Nick Harvey, Attorney-in-Fact
2021-04-01